U
PTX

UBS’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

UBS’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$253K Buy
+3,300
New +$260K ﹤0.01% 4951
2014
Q1 		– Sell
-75
Closed -$2K – 11166
2013
Q4 		$2K Sell
75
-813
-92% -$19.4K ﹤0.01% 10111
2013
Q3 		$24K Buy
888
+208
+31% +$6.69K ﹤0.01% 7846
2013
Q2 		$25K Buy
+680
New +$25.5K ﹤0.01% 7632

Other funds holding PTX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS's PTX Position: Q3 2014 in Review

UBS opened a new position in Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2014: 3,300 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #4951 among its holdings. This is a return to the name: UBS previously reported a position in PTX as recently as Q4 2013.

UBS first reported a position in PTX in Q2 2013 and has held it in 4 quarters since. 83 funds tracked by Wall St. Rank hold PTX as of Q3 2014.

  • UBS held 3,300 shares of Pernix Therapeutics Holdings, Inc. worth $253K as of Q3 2014.
  • Pernix Therapeutics Holdings, Inc. was a new UBS position in Q3 2014.
  • Pernix Therapeutics Holdings, Inc. made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4951 holding.
  • UBS first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and has held it in 4 quarters since.
  • 83 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.